Restricted cyclooxygenase-2 expression in the central nervous system following acute and delayed-type hypersensitivity responses to bacillus Calmette-Guerin

Neuroscience

Volumn 92, Issue 4, 1999, Pages 1405-1415

  Minghetti, L ^a   Hughes, P ^b   Perry, V H ^b  

^a Neurobiology Section   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Glial cells; Inflammation; Neutrophils; Perivascular macrophages; Prostaglandin; Prostaglandin endoperoxide H synthase

Indexed keywords

BCG VACCINE; CYCLOOXYGENASE 2; PROSTAGLANDIN; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HYPERSENSITIVITY REACTION; MALE; MICROGLIA; MONONUCLEAR PHAGOCYTE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CYCLOOXYGENASE 2; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MONOCYTES; MYCOBACTERIUM BOVIS; NEUTROPHILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR;

EID: 0033042294     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00739-8     Document Type: Article

References (47)

1. Adams J., Collaço-Moraes Y., De Belleroche J. Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66:1996;6-13.
2. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663:1994;237-243.
3. Aloisi F., Penna G., Cerase J., Menéndez Iglesias B., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1997;1604-1612.
4. Andersson P.B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48:1992;169-186.
5. Andersson P.B., Perry V.H., Gordon S. Intracerebral injection of proinflammatory cytokines or leukocytes chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. exp. Med. 176:1992;255-259.
6. Appleton I., Tomlinson A., Willoughby D.A. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv. Pharmac. 35:1996;27-78.
7. Au B.-T., Teixeira M.M., Collins P.D., Williams T.J. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils; synergism with prostanoids and salbutamol. Br. J. Pharmac. 123:1998;1260-1266.
8. Beauparlant P., Hiscott J. Biological and biochemical inhibitors of the NF-kB/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev. 7:1996;175-190.
9. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. comp. Neurol. 355:1995;296-315.
10. Caggiano A.O., Breder C.D., Kraing R. Long-term elevation of cyclooxygenase-2, but not lipoxygenase, in regions synaptically distant from spreading depression. J. comp. Neurol. 376:1996;447-462.
11. Cao C., Matsumura K., Yamagata K., Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis for fever. Brain Res. 733:1996;263-272.
12. Cao C., Matsumura K., Yamagata K., Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am. J. Physiol. 272:1997;R1712-R1725.
13. Chen J., Marsh T., Zhang J.S., Graham S.H. Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. NeuroReport. 6:1995;245-248.
14. Elmquist J.K., Breder C.D., Sherin J.E., Scammel T.E., Huckey W.F., Dewitt D., Saper C.B. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J. comp. Neurol. 381:1997;119-129.
15. 2 synthase (cyclooxygenase) in human monocytes. J. biol. Chem. 265:1990;16737-16740.
16. Graeber M.B., Streit W.J., Kreutzberg G.W. Identity of a ED2-positive perivascular cells in rat brain. J. Neurosci. Res. 22:1989;103-106.
17. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation. Science. 274:1996;1383-1385.
18. Herrmann F., Lindemann A., Gauss J., Mertelsmann R. Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymorphonuclear leukocytes involving activation and new synthesis of cyclooxygenase. Eur. J. Immunol. 20:1990;2513-2516.
19. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. natn. Acad. Sci. U.S.A. 93:1996;2317-2321.
20. Kopp E., Ghosh S. Inhibition of NF-kB by sodium salicylate and aspirin. Science. 265:1994;956-959.
21. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70:1998;452-466.
22. 2) on microglial functions. Biochemie, (in press).
23. Maclouf J. (1996) Transcellular biosynthesis of arachidonic acid metabolites: from in vitro investigation to in vivo reality. In Eicosanoids: from Biotechnology to Therapeutic Applications (eds Folco G. C., Samuelson B., Maclouf J. and Velo G.), Vol. 283, pp. 77-88. Plenum, New York.
24. Marcheselli V.L., Bazan N.G. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. J. biol. Chem. 271:1996;24794-24799.
25. Masferrer J.L., Zweifel B.S., Seibert K., Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. clin. Invest. 86:1990;1375-1379.
26. Matyszak M.K., Perry V.H. Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin. Neuroscience. 64:1995;967-977.
27. Matyszak M.K., Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience. 74:1996;599-608.
28. Matyszak M.K., Perry V.H. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteases. J. Neuroimmunol. 69:1996;141-149.
29. Matyszak M.K., Perry V.H. Bacillus Calmette-Guérin sequestered in the brain parenchyma escapes immune recognition. J. Neuroimmunol. 82:1998;73-80.
30. Matyszak M.K., Townsend M.J., Perry V.H. Ultrastructural studies of an immune-mediated inflammatory response in the CNS parenchyma directed against a non CNS antigen. Neuroscience. 78:1997;549-560.
31. 2. Proc. natn. Acad. Sci. U.S.A. 94:1997;6500-6505.
32. Minghetti L., Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65:1995;2690-2698.
33. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
34. Niiro H., Otsuka T., Yamaoka K., Ohshima K., Tanabe T., Hara S., Nemoto Y., Tanaka Y., Nakashima H., Niho Y. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood. 89:1997;1621-1628.
35. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
36. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., Coleman P.D. Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66:1996;2532-2540.
37. Perry V. H. (1994) Macrophages and the Nervous System. R. G. Landes Company, CRC, Austin, Texas.
38. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today. 12:1991;349-352.
39. Sanz O., Estrada A., Ferrer I., Planas A.M. Differential cellular distribution and dynamics of Hsp70, cyclooxygenase-2 and c-fos in the rat brain after transient focal ischemia or kainic acid. Neuroscience. 80:1997;221-232.
40. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenase-1 and -2). J. biol. Chem. 271:1996;33157-33160.
41. 2. J. exp. Med. 180:1994;2365-2370.
42. Talpain E., Amstrong R.A., Coleman R.A., Vardey C.J. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br. J. Pharmac. 114:1995;1459-1465.
43. 2 and a β-adrenergic agonist. Glia. 11:1994;383-386.
44. Tomlinson A., Appleton I., Moore A., Gilroy D.W., Willis D., Mitchell J.A., Willoughby D.A. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmac. 113:1994;693-698.
45. 2 is a potent inhibitor of human interleukin 12 production. J. exp. Med. 181:1995;775-779.
46. Weissmann G. Prostaglandins as modulators rather than mediators of inflammation. J. Lipid Mediat. 6:1993;275-286.
47. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.